Ai/Ml Expert Witnesses

Los Angeles, California

Software Engineering, Intellectual Property - Computer Graphics, AI/ML, Machine Learning, Augmented Reality, Virtual Reality, Image Processing, System Architecture, Distributed Systems, Cryptography, Rasterization, Visualization, 3D Modeling, 3D Animation, Patent Infringement, Copyright, Trade Secret Misappropriation, Breach-of-Contract

Dr. Iman Sadeghi is an award-winning computer scientist and software engineer, holding both a master’s and a doctoral degree in Computer Science from the University of California, San Diego. His illustrious career includes roles at tech giants such as Google, Walt Disney Animation Studios, and Lucasfilm. These valuable experiences have enriched his expertise across various aspects of computer science and software engineering disciplines. Currently, Dr. Sadeghi serves as a Principal Software & Technology Consultant at Quandary Peak Research, where he provides critical analysis in legal contexts. He provides deposition/trial testimony, reports, and declarations in the fields of computer graphics, 3D rendering and animation, 3D geometry processing, software engineering, system architecture, algorithms, and data structures. Dr. Sadeghi also conducts thorough source code analysis for software litigation. His work primarily addresses issues related to patent infringement, trade secret mi...

Landenberg, Pennsylvania

Statistics, Medical Devices - biostatistics, FDA, Pharmaceutical Statistics, Sanofi, Edwards, Gilead, AI/ML expert, machine learning, clinical trial, Medical Device, Vaccine, Group Sequential Design, Bayesian Adaptive Design, Statistical Review of Evidence, Oncology, Epidemiological, Regulatory Submissions, Survival Analysis, Statistical Expert Witness, RWE

Lei Li, PhD, is a biostatistician and former FDA CDRH statistical reviewer with extensive experience in regulatory statistics, Real-World Evidence (RWE), medical device submissions, and pharmaceutical development. At FDA, Dr. Li evaluated statistical components of 510(k) and PMA submissions, assessed safety and effectiveness evidence for medical devices, reviewed RWE and post-market studies, and advised on complex statistical issues for regulatory decision-making. His FDA work included evaluation of study design adequacy, endpoint justification, sample-size rationale, bias and confounding, missing data robustness, and interpretation of clinical performance metrics under regulatory standards. In industry, Dr. Li served as Statistical Project Leader at Sanofi and Principal Biostatistician at Edwards Lifesciences, supporting global clinical and regulatory programs across multiple therapeutic areas, including rare diseases, inflammatory diseases, vaccines, oncology, and cardiovascular ...